Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI107717

Biological Defense Mechanisms THE EFFECT OF BACTERIA AND SERUM ON SUPEROXIDE PRODUCTION BY GRANULOCYTES

John T. Curnutte and Bernard M. Babior

1Department of Medicine, Tufts-New England Medical Center Hospital, Boston, Massachusetts 02111

Find articles by Curnutte, J. in: PubMed | Google Scholar

1Department of Medicine, Tufts-New England Medical Center Hospital, Boston, Massachusetts 02111

Find articles by Babior, B. in: PubMed | Google Scholar

Published June 1, 1974 - More info

Published in Volume 53, Issue 6 on June 1, 1974
J Clin Invest. 1974;53(6):1662–1672. https://doi.org/10.1172/JCI107717.
© 1974 The American Society for Clinical Investigation
Published June 1, 1974 - Version history
View PDF
Abstract

We previously reported that granulocytes are able to produce superoxide (O2-), a highly reactive compound formed by the one-electron reduction of oxygen. The demonstration of O2- production was based on the observation that the reduction of extra-cellular cytochrome c by granulocytes was greatly diminished by superoxide dismutase, an enzyme catalyzing the conversion of O2- to hydrogen peroxide and oxygen. In the present report, studies concerning the effect of bacteria and serum on O2--dependent cytochrome c reduction by granulocytes are described.

In the absence of bacteria, the O2--dependent reduction of extracellular cytochrome c by granulocytes under optimal assay conditions amounted to 9.2±2.8 SD nmol/3 × 106 cells/20 min. When bacteria (100 organisms/cell) were present, the O2--dependent cytochrome c reduction under otherwise similar conditions increased by a factor of nearly four (34.5±9.4). There was no effect of albumin or catalase on cytochrome c reduction, and boiled dismutase had only a small effect. Omission of granulocytes or substitution of live cells by cells by cells killed by heat abolished O2--dependent cytochrome c reduction. Bacteria killed by autoclaving were almost as effective as live bacteria in stimulating granulocyte O2- production. Measurements of particle uptake and O2 uptake by granulocytes indicated that superoxide dismutase did not affect granulocyte metabolism nonspecifically, supporting the conclusion that the diminution of cytochrome c reduction in the presence of dismutase was due to the destruction of O2- by this enzyme.

Stimulation of O2- production by bacteria was strongly dependent on the presence of serum in the incubation mixture. Serum heated to 56°C for 45 min was as effective as unheated serum in stimulating O2- production in the presence of bacteria, but boiled serum had no effect. Other experiments suggested that incubation of bacteria with serum resulted in the release of a nonparticulate heat-labile substance capable of stimulating O2- production in the absence of bacteria.

Certain characteristics of the O2--dependent cytochrome c reduction by granulocytes were studied, including the dependence of this process on granulocyte, cytochrome c, and bacterial concentrations. In addition, O2--dependent cytochrome c reduction was followed as a function of time. A constant rate was found with resting granulocytes. With bacteria the time course was more complex. A well-defined lag was followed by a fairly brief period of extremely vigorous cytochrome c reduction. During this period, the maximum rate of cytochrome c reduction exceeded the rate observed in the absence of bacteria by a factor of 12. The rate then decreased until by 40 min, it had slowed to the rate observed in the absence of bacteria.

From the above results, it was concluded that the exposure of the granulocyte to bacteria plus serum initiates a process in which a defined quantity of O2- is formed in a rapid burst lasting 20-30 min. It is conceivable that the O2- generated by this process may be involved in the killing of bacteria by the granulocytes.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1662
page 1662
icon of scanned page 1663
page 1663
icon of scanned page 1664
page 1664
icon of scanned page 1665
page 1665
icon of scanned page 1666
page 1666
icon of scanned page 1667
page 1667
icon of scanned page 1668
page 1668
icon of scanned page 1669
page 1669
icon of scanned page 1670
page 1670
icon of scanned page 1671
page 1671
icon of scanned page 1672
page 1672
Version history
  • Version 1 (June 1, 1974): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts